AbbVie (ABBV) is a publicly traded Healthcare sector company. As of July 21, 2026, ABBV trades at $254.87 with a market cap of $449.45B and a P/E ratio of 125.31. ABBV moved -0.00% today. Year to date, ABBV is +10.77%; over the trailing twelve months it is +32.96%. Its 52-week range spans $164.39 to $261.64. Analyst consensus is strong buy with an average price target of $273.25. Rallies surfaces ABBV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ABBV combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $254.87 |
| Market Cap | $449.45B |
| P/E Ratio | 125.31 |
| EPS | $2.03 |
| Dividend Yield | 1.73% |
| 52-Week High | $261.64 |
| 52-Week Low | $164.39 |
| Volume | 230.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $62.82B |
| Net Income | $3.64B |
| Gross Margin | 70.68% |
22 analysts cover ABBV: 0 strong buy, 18 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $273.25.